De novo mutations in antithrombin deficiency: high frequency and heterogeneous mechanisms
Authors:
Open Access
- 29 January 2026
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 111 (7) , 2457-2462
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Identification of two de novo mutations responsible for type I antithrombin deficiencyThrombosis and Haemostasis, 2012
- Variation in genome-wide mutation rates within and between human familiesNature Genetics, 2011
- Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylationHaematologica, 2010
- Molecular basis of haemophilia AHaemophilia, 2004
- Homozygous Deficiency of Heparin Cofactor IICirculation, 2004
- Antithrombin Deficiency in Brazilian Patients with Venous Thrombosis: Molecular Characterization of a Single Splice Site Mutation, an Insertion and a De Novo Point MutationThrombosis Research, 2001
- Detection of two novel mutations (nt2762, exon 2, CAG to TAG, and nt2483 or 2484, exon 2, +A) in individuals with congenital type I antithrombin deficienciesBlood Coagulation & Fibrinolysis, 1999
- A novel and de novo spontaneous point mutation (Glu271STOP) of the antithrombin gene results in a type I deficiency and thrombophiliaAmerican Journal of Hematology, 1999
- Pleiotropic effects of antithrombin strand 1C substitution mutations.Journal of Clinical Investigation, 1992
- De novo splice site mutation in the antithrombin III (AT3) gene causing recurrent venous thrombosis: Demonstration of exon skipping by ectopic transcript analysisGenomics, 1992